科学杂志文章The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug

[billwanhua]

Science | AAAS

www.sciencemag.org

That infuriated the Solidarity team. "The mantra I've always heard as a joke about the FDA, is that they say ‘In God we trust, everyone else has to provide data,’” Kieny says. “So look at all the data."

Solidarity’s finings, WHO’s chief scientist, Soumya Swaminathan, notes that 50% of the 2750 patients who received remdesivir in the trial were from Canada and Europe, places recognized for high quality health care. And she stresses that the other participating countries do not necessarily have substandard care.

Questions have also arisen about the potential of remdesivir to do harm. WHO has a regular overview of possible adverse drug events related to COVID-19 treatments. In late August it noted a disproportionately high number of reports of liver and kidney problems in patients receiving remdesivir compared with patients receiving other drugs for COVID-19, The European Medicines Agency (EMA) also announced this month that its safety committee had started a review to assess reports of acute kidney injuries in some patients taking remdesivir.

 

[lindamy]

吃那个不需要批准，减少89% risk的维生素D不就行了吗？

 

[lindamy]

抗体疗法还有些希望。

1 hr 3 min ago
Covid-19 antibody therapies are showing promising early results in separate trials
From CNN's Jen Christensen

Days after Eli Lilly and Company said it would stop a trial of its Covid-19 antibody therapy in hospitalized patients because it was not effective, the company on Wednesday published promising interim results from a trial involving patients with mild and moderate Covid-19.

Also on Wednesday, biopharmaceutical company Regeneron reported its monoclonal antibody cocktail treatment helped people with mild and moderate Covid-19.

There are at least 78 monoclonal antibody treatments for Covid-19 in various stages of development in labs around the world, but those made by Lilly and Regeneron have been among the most closely watched. Both Lilly and Regeneron have already applied to the US Food and Drug Administration for emergency use authorizations that would open up their antibody treatments to more people with Covid-19.

Read more:


RELATED
Covid-19 antibody therapies show promising early results in separate trials

 

[lindamy]

7 min ago
The second-highest ranking officer in the US Space Force has tested positive for Covid-19
From CNN's Barbara Starr and Ryan Browne

Gen. David D. Thompson, the US Space Force's second-highest ranking officer, has tested positive for Covid-19, the US Air Force said in a statement Wednesday.

Thompson, who is the vice chief of space operations, took a test after a close family member tested positive for the virus.

“In accordance with established COVID policies, General Thompson is self-quarantining and working remotely from home,” the statement read.

The US Space Force is a newly formed military service branch structured within the Department of the Air Force.

The Space Force “trains, equips and maintains mission-ready space forces that provide missile warning, space domain awareness, positioning, navigation and timing, communications and space electronic warfare,” according to the US Defense Department.

Read more:


RELATED
Second highest ranking officer in US Space Force tests positive for Covid-19